Alterative pathway dysregulation has been found approximately in 50–70% of patients with C3-glomerulopathy (glomerular C3 deposition) and immune complex-associated membranoproliferative glomerulonephritis (glomerular Ig and complement deposition). Here, C3 is linked to glomerular disorder.